| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $454.6M | -8.1% |
| Gross Profit | $260.3M | -13.9% |
| R&D Expense | $1.7M | +142.9% |
| SG&A Expense | $262.2M | +5.1% |
| Operating Income | -$174.6M | +23.4% |
| Pre-tax Income | -$189.2M | +18.3% |
| Income Tax | -$9.0M | +75.3% |
| Net Income | -$180.2M | -61.8% |
| EPS (Basic) | -$1.94 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.0M | -39.6% |
| Accounts Receivable | $39.4M | -7.7% |
| Inventory | $108.6M | -2.7% |
| Current Assets | $172.2M | -12.2% |
| Total Assets | $495.1M | -24.9% |
| Current Liabilities | $121.7M | +37.4% |
| Long-term Debt | $150.7M | +1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.5M | -83.2% |
| Capital Expenditures | $14.5M | +59.6% |
| Investing Cash Flow | -$14.5M | +72.7% |
| Financing Cash Flow | -$3.7M | +71.6% |
| Free Cash Flow | -$4.0M | -107.5% |
| -5.4% |
| EPS (Diluted) | -$1.94 | -5.4% |
| Stockholders' Equity |
| $133.7M |
| -44.6% |